New! Sign up for our free email newsletter.
Science News
from research organizations

Survival molecule helps cancer cells hide from the immune system

Date:
October 7, 2014
Source:
Ohio State University Wexner Medical Center
Summary:
The molecule nuclear factor kappa B helps tumors grow by inhibiting the body's ability to detect cancer cells, research shows. The molecule suppresses immune surveillance mechanisms, including the production of cells that inhibit immune responses. The research suggests that cancer immune therapy might be improved if combined with NF-kB inhibitors, and it provides new details about interactions between cancer cells and non-cancer cells that assist tumor growth.
Share:
FULL STORY

A molecule that helps cancer cells evade programmed self-destruction, an internal source of death, might also help malignant cells hide from the immune system, an external source of death.

A new study by researchers at The Ohio State University Comprehensive Cancer Center -- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC -- James) shows that a molecule called nuclear factor kappa B (NF-kB) helps cancer cells by suppressing the immune system's ability to detect and destroy them. The molecule regulates genes that suppress immune surveillance mechanisms, including the production of cells that inhibit the immune response.

The research suggests that immune therapy for cancer might be more effective if combined with drugs that inhibit NF-kB. They also provide new details about how interactions between cancer cells and noncancer cells assist tumor growth.

The findings are published in the journal Cell Reports.

"We've long known that NF-kB promotes cancer development by subverting apoptosis, an internal safety mechanism that otherwise would cause cancer cells to self-destruct," says principal investigator Denis Guttridge, PhD, professor of molecular virology, immunology and medical genetics and of molecular and cellular biochemistry.

"This study shows that NF-kB might coordinate a network of immune-suppressor genes whose products enable tumor cells to evade adaptive immunity," he adds. "Therefore, inhibiting NF-kB will might make tumor cells more vulnerable to elimination by the immune system."

A 2009 study by the same researchers showed that NF-kB helps normal cells in DNA repair, which may prevent them from harming the body. However, it is hard to understand why such a molecule might act differently in cancer cells, where NF-kB is typically always in an active state.

For this study, Guttridge, first author David J. Wang, who developed many of the study's concepts, and their colleagues monitored NF-kB activity during tumor development using mouse embryonic fibroblasts and two mouse models. Key technical findings include:

  • During early tumor development, macrophages -- innate immune cells -- migrate into the tumor;
  • NF-kB enables cancer cells to survive the pro-apoptotic influence of tumor necrosis factor that is released by tumor infiltrating macrophages;
  • NF-kB may also regulate a number of genes related to immune suppression, particularly TGF-beta, IL-10, GM-CSF, G-CSF and VEGF.
  • In cancer cells with active NF-kB, shutting down TGF-beta expression removed its immune suppressive influence and delayed tumor growth, evidence that TGF-beta is a gene regulated by NF-kB that contributes to tumor development.

"Overall, our findings demonstrate that NF-kB might play a pivotal role in enabling cells to evade surveillance by both innate and adaptive immune cells," Guttridge says.


Story Source:

Materials provided by Ohio State University Wexner Medical Center. Note: Content may be edited for style and length.


Journal References:

  1. David J. Wang, Nivedita M. Ratnam, John C. Byrd, Denis C. Guttridge. NF-κB Functions in Tumor Initiation by Suppressing the Surveillance of Both Innate and Adaptive Immune Cells. Cell Reports, 2014; DOI: 10.1016/j.celrep.2014.08.049
  2. Jingxin Wang, Naduparambil K Jacob, Katherine J Ladner, Amer Beg, James D Perko, Stephan M Tanner, Sandya Liyanarachchi, Richard Fishel, Denis C Guttridge. RelA/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair. EMBO reports, 2009; 10 (11): 1272 DOI: 10.1038/embor.2009.197

Cite This Page:

Ohio State University Wexner Medical Center. "Survival molecule helps cancer cells hide from the immune system." ScienceDaily. ScienceDaily, 7 October 2014. <www.sciencedaily.com/releases/2014/10/141007152601.htm>.
Ohio State University Wexner Medical Center. (2014, October 7). Survival molecule helps cancer cells hide from the immune system. ScienceDaily. Retrieved March 28, 2024 from www.sciencedaily.com/releases/2014/10/141007152601.htm
Ohio State University Wexner Medical Center. "Survival molecule helps cancer cells hide from the immune system." ScienceDaily. www.sciencedaily.com/releases/2014/10/141007152601.htm (accessed March 28, 2024).

Explore More

from ScienceDaily

RELATED STORIES